Evidence for stepwise formation of amyloid fibrils by the mouse prion protein

Shweta Jain1, Jayant B Udgaonkar

  • 1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore 560065, India.

Insights

Mouse prion protein (moPrP) forms amyloid fibrils via beta-rich oligomers at low pH. Fibril formation involves multiple steps, with aggregate growth and conformational changes influencing the rate and structure.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Biophysics

Background:

  • Prion diseases are linked to misfolding and aggregation of prion proteins.
  • Understanding the structural transitions of prion proteins is crucial for disease research.

Purpose of the Study:

  • To investigate the mechanism of amyloid fibril formation by mouse prion protein (moPrP).
  • To characterize the conditions and kinetics of worm-like amyloid fibril formation from moPrP.

Main Methods:

  • Utilized biophysical techniques including circular dichroism, thioflavin fluorescence, dynamic light scattering, and total scattering intensity.
  • Studied the effect of pH, salt concentration, temperature, and protein concentration on fibril formation.
  • Determined the activation energy for fibril formation.

Main Results:

  • Mouse prion protein (moPrP) forms worm-like amyloid fibrils at pH 2 and 0.15 M NaCl.
  • Fibril formation proceeds from soluble beta-rich oligomers, not alpha-rich monomers.
  • Fibrillation rate is dependent on protein concentration, suggesting a multi-step process involving aggregate growth and conformational changes.
  • Activation energy for fibril formation was determined to be 129 kJ/mol.
  • Fibril morphology (length and number) varies with protein concentration.

Conclusions:

  • Mouse prion protein aggregation into amyloid fibrils is a complex, multi-step process.
  • Beta-rich oligomers are the direct precursors to worm-like amyloid fibrils.
  • Protein concentration influences the kinetics and structural outcome of moPrP fibrillation.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...